Venous Thromboembolism News and Research

RSS
FDA approves new indication for FRAGMIN for the extended treatment of symptomatic venous thromboembolism

FDA approves new indication for FRAGMIN for the extended treatment of symptomatic venous thromboembolism

Ban called for on newer birth control pills

Ban called for on newer birth control pills

Sticking to clinical guidelines decreases deep vein thrombosis in elderly

Sticking to clinical guidelines decreases deep vein thrombosis in elderly

No link between low air-pressure on long-haul flights and DVT

No link between low air-pressure on long-haul flights and DVT

DVT and long haul flights - air pressure and oxygen levels not the culprits

DVT and long haul flights - air pressure and oxygen levels not the culprits

Estrogen therapy may increase the risk of venous thrombosis

Estrogen therapy may increase the risk of venous thrombosis

Ximelagatran effective for preventing blood clots and stroke

Ximelagatran effective for preventing blood clots and stroke

New insight into anticoagulation therapies

New insight into anticoagulation therapies

Guidelines introduce novel therapies for the prevention and treatment of thrombosis

Guidelines introduce novel therapies for the prevention and treatment of thrombosis

Catheter delivered devices may be just as effective as drug therapy in treating strokes of unidentified origin

Catheter delivered devices may be just as effective as drug therapy in treating strokes of unidentified origin

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.